Tuberculosis control in big cities and urban risk groups in the European Union: A consensus statement

Eurosurveillance

Volumn 19, Issue 9, 2014, Pages

  van Hest, N A ^a   Aldridge, R W ^b   de Vries, G ^c   Sandgren, A ^d   Hauer, B ^e   Hayward, A ^b   de Oñate, W Arrazola ^f   Haas, W ^e   Codecasa, L R ^g   Cayla J A ^h   Story, A ⁱ   Antoine, D ^j   Gori, A ^k   Quabeck, L ^l   Jonsson, J ^m   Wanlin, M ^f   Orcau, A ^h   Rodes, A ⁿ   Dedicoat, M ^o   Antoun, F ^p   van Deutekom, H ^q   Keizer, S T ^q   Abubakar, I ^r   more..

^a Public Health Service of the Rotterdam Region   (Netherlands)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c KNCV TUBERCULOSIS FOUNDATION   (Netherlands)

^d EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

^e ROBERT KOCH INSTITUTE   (Germany)

^f Belgian Lung and Tuberculosis Association   (Belgium)

^g OSPEDALE NIGUARDA CA GRANDA   (Italy)

^h AGÈNCIA DE SALUT PÚBLICA DE BARCELONA   (Spain)

ⁱ Find and Treat   (United Kingdom)

^j INSTITUT DE VEILLE SANITAIRE   (France)

^k UNIVERSITY OF MILAN   (Italy)

^l Senate Dept for Health Environment and Consumer Protection   (Germany)

^m SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

ⁿ C Agy Hlth Technol Assess Res   (Spain)

^o Heart of England Hospital   (United Kingdom)

^p Municipal Public Health Service Amsterdam ^*

^q MUNICIPAL HEALTH SERVICE   (Netherlands)

^r PUBLIC HEALTH ENGLAND   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COST EFFECTIVENESS ANALYSIS; DISEASE TRANSMISSION; DNA FINGERPRINTING; EUROPEAN UNION; HEALTH CARE POLICY; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; INCIDENCE; INFECTION RISK; MASS SCREENING; MULTIDRUG RESISTANT TUBERCULOSIS; RISK FACTOR; TUBERCULOSIS CONTROL; URBAN POPULATION;

CITIES; CONSENSUS; EUROPE; EUROPEAN UNION; HUMANS; INCIDENCE; TUBERCULOSIS; URBAN POPULATION;

EID: 84896889985     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.ES2014.19.9.20728     Document Type: Article

References (140)

1. de Vries G, Aldridge RW, Caylà JA, Haas WH, Sandgren A, van Hest NA, Abubakar I, the Tuberculosis in European Union Big Cities Work. Epidemiology of tuberculosis in big cities of the European Union and European Economic Area countries. Euro Surveill. 2014;19(9):pii=20726.
2. Hayward AC, Darton T, Van-Tam JN, Watson JM, Coker R, Schwoebel V. Epidemiology and control of tuberculosis in Western European cities. Int J Tuberc Lung Dis. 2003;7(8):751-7.
3. Farge D, Porcher R, Antoun F, Fain O, Keshtmand H, Rocher G, et al. Tuberculosis in European cities: establishment of a patient monitoring system over 10 years in Paris, France. Int J Tuberc Lung Dis. 2007;11(9):992-8.
4. Bothamley GH Kruijshaar ME, Kunst H, Woltmann G, Cotton M, Saralaya D, et al. Tuberculosis in UK cities: workload and effectiveness of tuberculosis control programmes. BMC Public Health. 2011;11:896. http://dx.doi.org/10.1186/1471-2458-11-896
5. Caylà JA, Orcau A. The control of tuberculosis in large cities in developed countries; an organisational problem. BMC Med. 2011;9:127. http://dx.doi.org/10.1186/1741-7015-9-127
6. Solsona J, Caylà JA, Nadal J, Bedia M, Mata C, Brau J, et al. Screening for tuberculosis upon admission to shelters and free-meal services. Eur J Epidemiol. 2001;17(2):123-8. http://dx.doi.org/10.1023/A:1017580329538
7. Story A, Murad S, Roberts W, Verheyen M, Hayward AC. Tuberculosis in London: the importance of homelessness, problem drug use and prison. Thorax. 2007;62(8):667-71. http://dx.doi.org/10.1136/thx.2006.065409
8. Abubakar I, Crofts JP, Gelb D, Story A, Andrews N, Watson JM. Investigating urban-rural disparities in tuberculosis treatment outcome in England and Wales. Epidemiol Infect. 2008;136(1):122-7. http://dx.doi.org/10.1017/S0950268807008333
9. Kruijshaar ME, Abubakar I, Dedicoat M, Bothamley GH, Maguire H, Moore J, et al. Evidence for a national problem: continued rise in tuberculosis case numbers in urban areas outside London. Thorax. 2012;67(3):275-7. http://dx.doi.org/10.1136/thoraxjnl-2011-200850
10. Abubakar I, Stagg HR, Cohen T, Mangtani P, Rodrigues LC, Pimpin L, et al. Controversies and unresolved issues in tuberculosis prevention and control: a low-burden-country perspective. J Infect Dis. 2012;205 Suppl 2:S293-300. http://dx.doi.org/10.1093/infdis/jir886
11. National Institute for Health and Clinical Excellence (NICE). NICE public health guidance 37: identifying and managing tuberculosis among hard-to-reach groups. London: NICE; 2012. Available from:http://publications.nice.org.uk/identifying-and-managing-tuberculosis-among-hard-to-reach-groups-ph37
12. van Hest NA, de Vries G, van Gerven PJ, Baars HW. [Delay in the diagnosis of tuberculosis]. Ned Tijdschr Geneeskd. 2003;147(38):1825-9. Dutch.
13. de Vries G, van Hest RA. From contact investigation to tuberculosis screening of drug addicts and homeless persons in Rotterdam. Eur J Public Health. 2006;16(2):133-6. http://dx.doi.org/10.1093/eurpub/cki203
14. Faustini A, Hall AJ, Perucci CA. Tuberculosis treatment outcomes in Europe: a systematic review. Eur Respir J. 2005;26(3):503-10. http://dx.doi.org/10.1183/09031936.05.00103504
15. Caylà JA, Rodrigo T, Ruiz-Manzano J, Caminero JA, Vidal R, García JM, et al. Tuberculosis treatment adherence and fatality in Spain. Respir Res. 2009;10:121. http://dx.doi.org/10.1186/1465-9921-10-121
16. de Vries G, van Hest RA, Richardus JH. Impact of mobile radiographic screening on tuberculosis among drug users and homeless persons. Am J Respir Crit Care Med. 2007;176(2):201-7. http://dx.doi.org/10.1164/rccm.200612-1877OC
17. Jit J, Stagg H, Aldridge R, White P, Abubakar I. Dedicated outreach service for hard to reach patients with tuberculosis in London: observational study and economic evaluation. BMJ. 2011;343:d5376. http://dx.doi.org/10.1136/bmj.d5376
18. Goetsch U, Bellinger OK, Buettel KL, Gottschalk R. Tuberculosis among drug users and homeless persons: impact of voluntary X-ray investigation on active case finding. Infection. 2012;40(4):389-95. doi 10.007/s15010-011-0238-x.
19. Bernard C, Sougakoff W, Fournier A, Larnaudie S, Antoun F, Robert J, et al. Impact of a 14-year screening programme on tuberculosis transmission among the homeless in Paris. Int J Tuberc Lung Dis. 2012;16(5):649-55.
20. Hall J, Bethell S, Helleren S, Story A, Lipman M. Evaluation of TB peer educators-essential partners in metropolitan TB control. Thorax. 2010; 65: A5 doi:10.1136/thx.2010.150912.4. Available from:http://thorax.bmj.com/content/65/Suppl_4/A5.2.full.pdf+html http://dx.doi.org/10.1136/thx.2010.150912.4
21. Ospina JE, Orcau A, Millet JP, Sánchez F, Casals M, Caylà JA. Community health workers improve contact tracing among immigrants with tuberculosis in Barcelona. BMC Public Health. 2012;12:158 doi:10.1186/1471-2458-12-158. http://dx.doi.org/10.1186/1471-2458-12-158
22. Person AK, Blain ML, Jiang H, Rasmussen PW, Stout JE. Text messaging for enhancement of testing and treatment for tuberculosis, human immunodeficiency virus, and syphilis: a survey of attitudes toward cellular phones and healthcare. Telemed J E Health. 2011;17(3):185-9. http://dx.doi.org/10.1089/tmj.2010.0164
23. Krueger K, Ruby D, Cooley P, Montoya B, Exarchos A, Djojonegoro BM, et al. Videophone utilization as an alternative to directly observed therapy for tuberculosis. Int J Tuberc Lung Dis. 2010;14(6):779-81.
24. de Vries G, van Hest NA, Baars HW, Sebek MM, Richardus JH. Factors associated with the high tuberculosis case rate in an urban area. Int J Tuberc Lung Dis. 2010;14(7):859-65.
25. van Deutekom H, Gerritsen JJ, van Soolingen D, van Ameijden EJ, van Embden JD, Coutinho RA. A molecular epidemiological approach to studying the transmission of tuberculosis in Amsterdam. Clin Infec Dis. 1997;25(5):1071-7. http://dx.doi.org/10.1086/516072
26. Dahle UR, Eldholm V, Winje BA, Mannsåker T, Heldal E. Impact of immigration on the molecular epidemiology of Mycobacterium tuberculosis in a low-incidence country. Am J Respir Crit Care Med. 2007;176(9):930-5. http://dx.doi.org/10.1164/rccm.200702-187OC
27. Solsona J, Caylà JA, Verdú E, Estrada MP, Garcia S, Roca D, et al. Molecular and conventional epidemiology of tuberculosis in an inner city district. Int J Tuberc Lung Dis. 2001;5(8):724-31.
28. European Centre for Disease Prevention and Control (ECDC). Framework Action Plan to fight tuberculosis in the European Union. Stockholm: ECDC; 2008.
29. Quabeck L, Abubakar I, Antoine D, Bergren I, Erkens C, Indra A, et al. Comparative analysis of tuberculosis epidemiology in capitals and countries in the west/EU-EuroTB region. Abstract book of the 5th Congress of the International Union against Tuberculosis and Lung Disease; 2009 May 27-30; Dubrovnik, Croatia: p. 57.
30. Veen J, Migliori GB, Raviglione M, Rieder HL, Dara M, Falzon D, et al. Harmonisation of TB control in the WHO European region: the history of the Wolfheze Workshops. Eur Respir J. 2011;37(4):950-9. http://dx.doi.org/10.1183/09031936.00019410
31. Story A. Epidemiology and control of tuberculosis in hard to reach groups in London. [academic thesis]. Amsterdam: University of Amsterdam; 2012.
32. Harbour R, Miller J. A new system for grading recommendations in evidence based guidelines. BMJ. 2001;323(7308):334-6 http://dx.doi.org/10.1136/bmj.323.7308.334
33. European Centre for Disease Prevention and Control/WHO Regional Office for Europe. Tuberculosis surveillance and monitoring in Europe 2012. Stockholm: European Centre for Disease Prevention and Control, 2012. Available from:http://ecdc.europa.eu/en/publications/publications/1203-annual-tb-report.pdf
34. Semenza JC. Strategies to intervene on social determinants of infectious diseases. Euro Surveill. 2010;15(27):pii=19611.
35. Semenza JC, Giesecke J. Intervening to reduce inequalities in infections in Europe. Am J Public Health. 2008;98(5):787-92. http://dx.doi.org/10.2105/AJPH.2007.120329
36. Suk J, Manissero D, Buscher G, Semenza JC. Wealth inequality and TB elimination in Europe. Emerg Infect Dis. 2009;15(11):1812-4. http://dx.doi.org/10.3201/eid1511.090916
37. Ploubidis GB, Palmer MJ, Blackmore C, Lim TA, Manissero D, Sandgren A, et al. Social determinants of tuberculosis in Europe: a prospective ecological study. Eur Respir J. 2012;40(4):925-30 http://dx.doi.org/10.1183/09031936.00184011
38. Álvarez JL, Kunst AE, Leinsalu M, Bopp M, Strand BH, Menvielle G, et al. Educational inequalities in TB mortality in sixteen European populations. Int J Tuberc Lung Dis. 2011;15(11):1461-7. http://dx.doi.org/10.5588/ijtld.10.0252
39. van der Werf M, Giesecke J, Sprenger M. Can the economic crisis have an impact on tuberculosis in the EU/EEA? Euro Surveill. 2012;17(12):pii=20122.
40. Hargreaves JR, Boccia D, Evans CA, Adato M, Petticrew M, Porter JD. The social determinant of TB: from evidence to action. Am J Public Health. 2011;101(4):654-62. http://dx.doi.org/10.2105/AJPH.2010.199505
41. Oren E, Koepsell T, Leroux BG, Mayer J. Area-based socio-economic disadvantage and tuberculosis incidence. Int J Tuberc Lung Dis. 2012;16(7):880-5. http://dx.doi.org/10.5588/ijtld.11.0700
42. Mangtani P, Jolley DJ, Watson JM, Rodrigues LC. Socioeconomic deprivation and notification rates for tuberculosis in London during 1982-91. BMJ. 1995;310(6985):963-6. http://dx.doi.org/10.1136/bmj.310.6985.963
43. Bhatti N, Law MR, Morris JK, Halliday R, Moore-Gillon J. Increasing incidence of TB in England and Wales: a study of the likely causes. BMJ. 1995;310(6985):967-9. http://dx.doi.org/10.1136/bmj.310.6985.967
44. Baker M, Das D, Venugopal K, Howden-Chapman P. Tuberculosis associated with household crowding in a developed country. J Epidemiol Community Health. 2008;62(8):715-21. http://dx.doi.org/10.1136/jech.2007.063610
45. Story A, van Hest R, Hayward A. Tuberculosis and social exclusion. BMJ. 2006;333(7558):57-8. http://dx.doi.org/10.1136/bmj.333.7558.57
46. Craig GM, Booth H, Story A, Hayward A, Hall J, Goodburn A, et al. The impact of social factors on tuberculosis management. J Adv Nurs. 2007;58(5):418-24. http://dx.doi.org/10.1111/j.1365-2648.2007.04257.x
47. Craig GM, Booth H, Hall J, Story A, Hayward A, Goodburn A, et al. Establishing a new service role in tuberculosis care: the tuberculosis link worker. J Adv Nurs. 2008;61(4):413-24. http://dx.doi.org/10.1111/j.1365-2648.2007.04498.x
48. Story A, Slockers M, Arrazola de Onate W, Hewett N, van Hest R. Homeless Health Services, Tuberculosis and Economic Crisis: A Tale of Three Cities. Homeless in Europe: Spring 2011. [Accessed 9 June 2012] Available from:http://feantsa.horus.be/files/freshstart/Communications/Homeless%20in%20Europe%20EN/PDF_2011/Homeless_in_Europe_Spring_2011.pdf
49. LoBue PA, Cass R, Lobo D, Moser K, Catanzaro A. Development of housing programs to aid in the treatment of tuberculosis in homeless individuals: a pilot study. Chest. 1999;115(1):218-23. http://dx.doi.org/10.1378/chest.115.1.218
50. Díez E, Clavería J, Serra T, Caylà JA, Jansà JM, Pedro R, et al. Evaluation of a social health intervention among homeless tuberculosis patients. Tuber Lung Dis. 1996;77(5):420-4. http://dx.doi.org/10.1016/S0962-8479(96)90114-8
51. Tulsky JP, Pilote L, Hahn JA, Zolopa, AJ, Burke M, Chesney M, et al. Adherence to isoniazid prophylaxis in the homeless: a randomized controlled trial. Arch Intern Med. 2000; 160(5):697-702. http://dx.doi.org/10.1001/archinte.160.5.697
52. Heldal E, Kuyvenhoven JV, Wares F, Migliori GB, Ditiu L, Fernandez de la Hoz K, et al. Diagnosis and treatment of tuberculosis in undocumented migrants in low-or intermediate-incidence countries. Int J Tuberc Lung Dis. 2008;12(8):878-88.
53. Harstad I, Heldal E, Steinshamn SL, Garåsen H, Jacobsen GW. Tuberculosis screening and follow-up of asylum seekers in Norway: a cohort study. BMC Public Health. 2009:14;9:141.
54. Dara M, de Colombani P, Petrova-Benedict R, Centis R, Zellweger JP, Sandgren A, et al. Minimum package for cross-border TB control and care in the WHO European Region: a Wolfheze consensus statement. Eur Respir J. 2012 40(5):1081-1090. http://dx.doi.org/10.1183/09031936.00053012
55. Roy A, Abubakar I, Chapman A, Andrews N, Pattinson M, Lipman M, et al. A controlled trial of the knowledge impact of TB information leaflets among staff supporting substance misusers: pilot study. PLoS One. 2011;6(6):e20875. http://dx.doi.org/10.1371/journal.pone.0020875
56. Roy A, Abubakar I, Yates S, Chapman A, Lipman M, Monk P, Catchpole M, et al. Evaluating knowledge gain from TB leaflets for prison and homeless sector staff: the National Knowledge Service TB pilot. Eur J Public Health. 2008;18(6):600-3. http://dx.doi.org/10.1093/eurpub/ckn096
57. Department of Health. Stopping TB in England: Chief Medical Officer's Action Plan. London, Department of Health, 2004. Available from:http://webarchive.nationalarchives.gov.uk/20130107105354/http:/www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_4100860.pdf
58. Griffiths C, Sturdy P, Brewin P, Bothamley G, Eldridge S, Martineau A, et al. Educational outreach to promote screening for TB in primary care: a cluster randomised controlled trial. Lancet. 2007;369 (9572):1528-34. http://dx.doi.org/10.1016/S0140-6736(07)60707-7
59. Bothamley GH, Rowan JP, Griffiths CJ, Beeks M, McDonald M, Beasley E, et al. Screening for TB: the port of arrival scheme compared with screening in general practice and the homeless. Thorax. 2002;57(1):45-49. http://dx.doi.org/10.1136/thorax.57.1.45
60. Nnoaham KE, Pool R, Bothamley G, Grant AD. Perceptions and experiences of TB among African patients attending a TB clinic in London. Int J Tuberc Lung Dis. 2006;10(9):1013-7.
61. Nkulu FK, Hurtig AK, Ahlm C, Krantz I. Screening migrants for TB-a missed opportunity for improving knowledge and attitudes in high-risk groups: A cross-sectional study of Swedish-language students in Umeå, Sweden. BMC Public Health. 2010;10:349. http://dx.doi.org/10.1186/1471-2458-10-349
62. Roy A, Anaraki S, Hardelid P, Catchpole M, Rodrigues LC, Lipman M, et al. Universal HIV testing in London tuberculosis clinics: cluster randomised controlled trial. Eur Respir J. 2013;41(3):627-34. http://dx.doi.org/10.1183/09031936.00034912
63. Migliori GB, Zellweger JP, Abubakar I, Ibraim E, Caminero JA, De Vries G, et al. European union standards for tuberculosis care. Eur Respir J. 2012;39(4):807-19. http://dx.doi.org/10.1183/09031936.00203811
64. Sotgiu G, D'Ambrosio L, Centis R, Bothamley G, Cirillo DM, De Lorenzo S, et al. TB and M/XDR-TB infection control in European TB reference centres: the Achilles' heel? Eur Respir J. 2011;38(5):1221-3. http://dx.doi.org/10.1183/09031936.00029311
65. Paolo WF Jr, Nosanchuk JD. TB in New York City: recent lessons and a look ahead. Lancet Infect Dis. 2004;4(5):287-93. http://dx.doi.org/10.1016/S1473-3099(04)01004-7
66. Dharmadhikari AS, Mphahlele M, Stoltz A, Venter K, Mathebula R, Masotla T, et al. Surgical face masks worn by multidrug-resistant tuberculosis patients: Impact on infectivity of air on a hospital ward. Am. J Respir Med Crit Care. 2012;185(10):1104-9. http://dx.doi.org/10.1164/rccm.201107-1190OC
67. Lemaître N, Sougakoff W, Truffot-Pernot C, Cambau E, Derenne JP, Bricaire F, et al. Use of DNA fingerprinting for primary surveillance of nosocomial tuberculosis in a large urban hospital: detection of outbreaks in homeless people and migrant workers. Int J Tuberc Lung Dis. 1998;2(5):390-6.
68. Hannan MM, Peres H, Maltez F, Hayward AC, Machado J, Morgado A, Proenca R, et al. Investigation and control of a large outbreak of multi-drug resistant tuberculosis at a central Lisbon hospital. J Hosp Infect. 2001;47(2):91-7. http://dx.doi.org/10.1053/jhin.2000.0884
69. Moro ML, Errante I, Infuso A, Sodano L, Gori A, Orcese CA, et al. Effectiveness of infection control measures in controlling a nosocomial outbreak of multidrug-resistant tuberculosis among HIV patients in Italy. Int J Tuberc Lung Dis. 2000;4(1):61-8.
70. Couceiro L, Santana P, Nunes C. Pulmonary tuberculosis and risk factors in Portugal: a spatial analysis. Int J Tuberc Lung Dis. 2011;15(11):1445-54. http://dx.doi.org/10.5588/ijtld.10.0302
71. Diel R, Meywald-Walter K, Gottschalk R, Rüsch-Gerdes S, Niemann S. Ongoing outbreak of tuberculosis in a low-incidence community: a molecular-epidemiological evaluation. Int J Tuberc Lung Dis. 2004;8(7):855-61.
72. Lukacs J, Tubak V, Mester J, Dávid S, Bártfai Z, Kubica T, et al. Conventional and molecular epidemiology of tuberculosis in homeless patients in Budapest, Hungary. J Clin Microbiol. 2004;42(12):5931-4. http://dx.doi.org/10.1128/JCM.42.12.5931-5934.2004
73. Valin N, Antoun F, Chouaïd C, Renard M, Dautzenberg B, Lalande V, et al. Outbreak of tuberculosis in a migrant's shelter, Paris, France, 2002. Int J Tuberc Lung Dis. 2005;9(5):528-33.
74. Ködmön C, Niemann S, Gutierrez MC, Sola C, Rastogi N, Lukács J, et al. Molecular clues of a microepidemy among homeless tuberculosis patients in Budapest due to a new and local Mycobacterium tuberculosis clade. Infect Genet Evol. 2007;7(5): 632-5. http://dx.doi.org/10.1016/j.meegid.2007.06.003
75. Fernandez de la Hoz K, Inigo J, Fernandez-Martin JI, Arce A, Alonso-Sanz M, Gomez-Pintado P, et al. The influence of HIV infection and imprisonment on dissemination of Mycobacterium tuberculosis in a large Spanish city. Int J Tuberc Lung Dis. 2001;5(8):696-702.
76. Bothamley GH, Ditiu L, Migliori GB, Lange C; TBNET contributors. Active case finding of tuberculosis in Europe: a Tuberculosis Network European Trials Group (TBNET) survey. Eur Respir J. 2008;32(4):1023-30. http://dx.doi.org/10.1183/09031936.00011708
77. Klinkenberg E, Manissero D, Semenza JC, Verver S. Migrant tuberculosis screening in the EU/EEA: yield, coverage and limitations. Eur Respir J. 2009;34(5):1180-9. http://dx.doi.org/10.1183/09031936.00038009
78. Erkens CG, Kamphorst M, Abubakar I, Bothamley GH, Chemtob D, Haas W, et al. Tuberculosis contact investigation in low prevalence countries: a European consensus. Eur Respir J. 2010;36(4):925-49. http://dx.doi.org/10.1183/09031936.00201609
79. Coker R, Bell A, Pitman R, Zellweger JP, Heldal E, Hayward A, et al. Tuberculosis screening in migrants in selected European countries shows wide disparities. Eur Respir J. 2006;27(4):801-7. http://dx.doi.org/10.1183/09031936.06.00104305
80. van Hest R, Story A. Tuberculosis control among homeless persons in the European Union: more than words alone. ENHW Newsletter. 2008;6:4-7. Available from: http://www.feantsa.org/spip.php?article387&lang=en.
81. National Institute for Health and Clinical Excellence (NICE). NICE clinical guideline 117 TB: clinical diagnosis and management of TB, and measures for its prevention and control. London; NICE;, 2011. Available from:http://publications.nice.org.uk/tuberculosis-cg117
82. Dasgupta K, Menzies D. Cost-effectiveness of tuberculosis control strategies among immigrants and refugees. Eur Respir J. 2005;25(6):1107-16. http://dx.doi.org/10.1183/09031936.05.00074004
83. Jones TF, Schaffner W. Miniature chest radiograph screening for tuberculosis in jails: a cost-effectiveness analysis. Am J Respir Crit Care Med. 2001;164(1):77-81. http://dx.doi.org/10.1164/ajrccm.164.1.2010108
84. Erkens C, Slump E, Kamphorst M, Keizer S, van Gerven PJ, Bwire R, et al. Coverage and yield of entry and follow-up screening for tuberculosis among new immigrants. Eur Respir J. 2008;32(1):153-61. http://dx.doi.org/10.1183/09031936.00137907
85. Southern A, Premaratne N, English M, Balzs J, O'Sullivan D. Tuberculosis among homeless people in London: an effective model of screening and treatment. Int J Tuberc Lung Dis. 1999;3(11):1001-8.
86. van Hest NA, De Vries G, Smit F, Grant AD, Richardus JH. Estimating the coverage of a targeted mobile tuberculosis screening programme among illicit drug users and homeless persons with truncated models. Epidemiol Infect. 2008;136(5):628-35. http://dx.doi.org/10.1017/S0950268807009235
87. Kmietowicz Z. NICE advises screening for TB in hostels and prisons to reduce UK cases. BMJ. 2012;344: e2309. doi: 10.1136/bmj.e2309. http://dx.doi.org/10.1136/bmj.e2309
88. European Centre for Disease Prevention and Control (ECDC) and European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Prevention and control of infectious diseases among people who inject drugs. Stockholm: ECDC; 2011. Available from: http://www.emcdda.europa.eu/publications/ecdc-emcdda-guidance
89. Mulder C, Klinkenberg E, Manissero D. Effectiveness of tuberculosis contact tracing among migrants and the foreign born population. Euro Surveill 2009;14(11):pii=19153.
90. Fox GJ, Dobler CC, Marks GB. Active case finding in contacts of people with tuberculosis. Cochrane Database Syst Rev. 2011;(9):CD008477.
91. Mulder C, van Deutekom H, Huisman EM, Meijer-Veldman W, Erkens CG, van Rest J, et al. Coverage and yield of tuberculosis contact investigations in the Netherlands. Int J Tuberc Lung Dis. 2011;15(12):1630-7. http://dx.doi.org/10.5588/ijtld.11.0027
92. Balasegaram S, Grant R, Ormerod P, Mant J, Hayward J, Lowe D, et al. A survey of tuberculosis clinic provision in England and Wales. Public Health. 2008;122(6):602-12. http://dx.doi.org/10.1016/j.puhe.2007.09.015
93. New York City Department of Health and Mental Hygiene (NYCDH). Annual Summary 2008: New York City is Stopping TB. New York: NYCDH; 2009. Available from:http://www.nyc.gov/html/doh/downloads/pdf/tb/tb_annualsummary08.pdf
94. Pop-Eleches C, Thirumurthy H, Habyarimana JP, Zivin JG, Goldstein MP, de Walque D, et al. Mobile phone technologies improve adherence to antiretroviral treatment in a resource limited setting: a randomised controlled trial of text message reminders. AIDS. 2011;25(6):825-34. http://dx.doi.org/10.1097/QAD.0b013e32834380c1
95. Van den Boogaard J, Lyimo RA, Boeree MJ, Kibiki GS, Aarnoutse RE. Electronic monitoring of treatment adherence and validation of alternative adherence measures in tuberculosis patients: a pilot study. Bull World Health Organ. 2011;89(9):632-9. http://dx.doi.org/10.2471/BLT.11.086462
96. Magis-Escurra C, Miedema JR, de Lange WC, van Ingen J, Dekhuijzen PN, Boeree MJ. [Characteristics and treatment of tuberculosis patients in Dekkerswald, 2000-2005]. Ned Tijdschr Geneeskd. 2008;152(11):622-6. Dutch.
97. Geerligs WA, Van Altena R, De Lange WCM, Van Soolingen D, Van Der Werf TS. Multidrug-resistant tuberculosis: long-term treatment outcome in the Netherlands. Int J Tuberc Lung Dis. 2000;4(8):758-64.
98. Munsiff SS, Ahuja SD, King L, Udeagu CC, Dorsinville M, Frieden TR, et al. Ensuring accountability: the contribution of the cohort review method to tuberculosis control in New York City. Int J Tuberc Lung Dis. 2006;10(10):1133-9.
99. Rodrigo T, Caylà JA, Galdós-Tangüis H, García de Olalla P, Brugal MT, Jansà JM. Proposing indicators for evaluation of tuberculosis control programmes in large cities based on the experience of Barcelona. Int J Tuberc Lung Dis. 2001;5(5):432-40.
100. D'Lugoff MI, Jones W, Kub J, Glass N, Thompson D, Brinkley-Laughon S, et al. Tuberculosis screening in an at-risk immigrant Hispanic population in Baltimore city: an academic health center/local health department partnership. J Cult Divers. 2002;9(3):79-85.
101. Anderson C, Story A, Brown T, Drobniewski F, Abubakar I. Tuberculosis in UK prisoners: a challenge for control. J Epidemiol Community Health. 2010;64(4):373-6. http://dx.doi.org/10.1136/jech.2009.094375
102. Roberts CA, Lobato MN, Bazerman LB, Kling R, Reichard AA, Hammett TM. Tuberculosis prevention and control in large jails: a challenge to tuberculosis elimination. Am J Prev Med. 2006;30(2):125-30. http://dx.doi.org/10.1016/j.amepre.2005.10.018
103. Nutini S, Fiorenti F, Codecasa LR, Casali L, Besozzi G, Di Pisa G, et al. Hospital admission policy for tuberculosis in pulmonary centres in Italy: a national survey. AIPO Tuberculosis Study Group. Italian Association of Hospital Pulmonologists. Int J Tuberc Lung Dis. 1999;3(11):985-91.
104. Thomas JA, Laraque F, Munsiff S, Piatek A, Harris TG. Hospitalizations for tuberculosis in New York City: how many could be avoided? Int J Tuberc Lung Dis. 2010;14(12):1603-12.
105. Royal College of Nursing. Tuberculosis case management and cohort review. Guidance for health professionals. London: Royal College Nursing; 2012. Available from:https://www.rcn.org.uk/__data/assets/pdf_file/0010/439129/004204.pdf
106. Volmink J, Garner P. Directly observed therapy for treating tuberculosis. Cochrane Database Syst Rev. 2007;(4):CD003343.
107. Brent Refugee Forum. Knowledge, perceptions and barriers and the social meaning of tuberculosis among asylum seekers, homeless people and refugee communities in Brent 2004-2006. London: Brent Refugee Forum; 2007.
108. Belling R, Woods L, Boudioni M, McLaren S. Pan London Tuberculosis services: An audit evaluation. Institute for Strategic Leadership and Improvement. London: London South Bank University; 2008.
109. European Centre for Disease Prevention and Control (ECDC). Use of interferon-gamma release assays in support of TB diagnosis. Stockholm: ECDC; 2011. Available from:http://ecdc.europa.eu/en/publications/publications/1103_gui_igra.pdf
110. Miller TL, Hilsenrath P, Lykens K, McNabb SJ, Moonan PK, Weis SE. Using cost and health impacts to prioritize the targeted testing of tuberculosis in the United States. Ann Epidemiol. 2006;16(4):305-12. http://dx.doi.org/10.1016/j.annepidem.2005.07.053
111. Moonan PK, Oppong J, Sahbazian B, Singh KP, Sandhu R, Drewyer G, et al. What is the outcome of targeted tuberculosis screening based on universal genotyping and location? Am J Respir Crit Care Med. 2006;174(5):599-604. http://dx.doi.org/10.1164/rccm.200512-1977OC
112. Nienhaus A, Schablon A, Costa JT, Diel R. Systematic review of cost and cost-effectiveness of different TB-screening strategies. BMC Health Serv Res. 2011;11:247. http://dx.doi.org/10.1186/1472-6963-11-247
113. Verver S, Bwire R, Borgdorff MW. Screening for pulmonary TB among immigrants: estimated effect on severity of disease and duration of infectiousness. Int J Tuberc Lung Dis. 2001;5(5):419-25.
114. Pareek M, Watson JP, Ormerod LP, Kon OM, Woltmann G, White PJ, et al. Screening of immigrants in the UK for imported latent tuberculosis: a multicentre cohort study and cost-effectiveness analysis. Lancet Infect Dis. 2011;11(6):435-44. http://dx.doi.org/10.1016/S1473-3099(11)70069-X
115. Pareek M, Abubakar I, White PJ, Garnett GP, Lalvani A. Tuberculosis screening of migrants to low-burden nations: insights from evaluation of UK practice. Eur Respir J. 2011;37(5):1175-82. http://dx.doi.org/10.1183/09031936.00105810
116. Mandalakas AM, Menzies D. Is screening immigrants for latent tuberculosis cost-effective? Lancet Infect Dis. 2011;11(6):418-9. http://dx.doi.org/10.1016/S1473-3099(11)70102-5
117. Brewin P, Jones A, Kelly M, McDonald M, Beasly E, Sturdy P, et al. Is screening for tuberculosis acceptable for immigrants? A qualitative study. J Public Health (Oxf). 2006;28(3):253-60. http://dx.doi.org/10.1093/pubmed/fdl031
118. Kong PM, Tapy J, Calixto P, Burman WJ, Reves RR, Yang Z, et al. Skin-test screening and tuberculosis transmission among the homeless. Emerg Infect Dis. 2002;8(11):1280-4. http://dx.doi.org/10.3201/eid0811.020306
119. Ritter C, Elger BS. Prevalence of positive tuberculosis skin tests during 5 years of screening in a Swiss remand prison. Int J Tuberc Lung Dis. 2012;16(1):65-9. http://dx.doi.org/10.5588/ijtld.11.0159
120. Marco A, Solé N, Orcau A, Escribano M, Quintero S, et al. Prevalence of latent tuberculosis infection in inmates recently incarcerated in a men's prison in Barcelona. Int J Tuberc Lung Dis. 2012;16(1):60-4. http://dx.doi.org/10.5588/ijtld.11.0007
121. Sterling TR, Villarino ME, Borisov AS, Shang N, Gordin F, Bliven-Sizemore E, et al. Three months of rifapentine and isoniazid for latent tuberculosis infection. N Engl J Med. 2011;365(23):2155-66. http://dx.doi.org/10.1056/NEJMoa1104875
122. Sharma SK, A, Kadhiravan T, Tharyan P. Rifamycines (rifampicin, rifabutin and rifapentin) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB. Cochrane Database Syst Rev. 2013;(7):CD007545.
123. Lange C, Rieder HL. Intention to test is intention to treat. Am J Respir Crit Care Med. 2011;183(1):3-4. http://dx.doi.org/10.1164/rccm.201011-1881ED
124. van Deutekom H. Conventional and molecular epidemiological studies on tuberculosis. [academic thesis]. Amsterdam: University of Amsterdam; 2006.
125. de Vries G. DNA fingerprinting for TB control in a metropolitan area. [academic thesis]. Rotterdam: Erasmus University; 2009.
126. Glynn JR, Bauer J, de Boer AS, Borgdorff MW, Fine PE, Godfrey-Faussett P, et al. Interpreting DNA fingerprint clusters of Mycobacterium tuberculosis. European Concerted Action on Molecular Epidemiology and Control of Tuberculosis. Int J Tuberc Lung Dis. 1999;3(12):1055-60.
127. Mathema B, Kurepina NE, Bifani PJ, Kreiswirth BN. Molecular epidemiology of tuberculosis: current insights. Clin Microbiol Rev. 2006;19(4):658-85. http://dx.doi.org/10.1128/CMR.00061-05
128. Fok A, Numata Y, Schulzer M, Fitzgerald MJ. Risk factors for clustering of tuberculosis cases: a systematic review of population-based molecular epidemiology studies. Int J Tuberc Lung Dis. 2008;12(5):480-92.
129. European Centre for Disease Prevention and Control (ECDC). Progressing towards TB elimination. A follow-up to the Framework Action Plan to Fight Tuberculosis in the European Union. Stockholm: ECDC; 2010. Available from:http://ecdc.europa.eu/en/publications/publications/101111_spr_progressing_towards_tb_elimination.pdf
130. de Vries G, van Hest RA, Burdo CC, van Soolingen D, Richardus JH. A Mycobacterium tuberculosis cluster demonstrating the use of genotyping in urban tuberculosis control. BMC Infect Dis. 2009;9:151. http://dx.doi.org/10.1186/1471-2334-9-151
131. Hayward J, Murray D, Iny I, Jarrett J, Lonergan K, Pillas D, et al (Public Health Action Support Team (PHAST). London TB Service Review and Health Needs Assessment. London: PHAST; 2010. Available from: https://www.brit-thoracic.org.uk/Portals/0/Clinical%20Information/Tuberculosis/P263%20PHAST%20London%20TB%20Project%20Final%20report%20I.pdf
132. Decree of 27 October 2008, laying down new requirements regarding public health matters (Public Health Decree). Bulletin of Acts, Orders and Decrees in the Netherlands: 2008; 461. Available from:http://www.ilo.org/wcmsp5/groups/public/---ed_protect/---protrav/---ilo_aids/documents/legaldocument/wcms_127978.pdf.
133. Health Council of the Netherlands. Law on tuberculosis screening among the population. The Hague, Health Council of the Netherlands, 1999.
134. Health Council of the Netherlands: Committee on ethical and legal aspects of tuberculosis control, compulsion and pressure in tuberculosis control. The Hague, Health Council of the Netherlands (1996/07), 1996.
135. General Assembly of the United Nations. The Universal Declaration of Human Rights. 1948. Available from:http://www.un.org/Overview/rights.html
136. Council of Europe. European Convention for the Protection of Human Rights and Fundamental Freedoms, as amended by Protocols Nos. 11 and 14. 1950. Available from:http://conventions.coe.int/treaty/en/treaties/html/005.htm
137. Coker R. Compulsory screening of immigrants for tuberculosis and HIV. BMJ. 2004;328(7435):298-300. http://dx.doi.org/10.1136/bmj.328.7435.298
138. Coker RJ. Public health impact of detention of individuals with tuberculosis: systematic literature review. Public Health. 2003;117(4):281-7. http://dx.doi.org/10.1016/S0033-3506(03)00035-0
139. Coker R. Just coercion? Detention of nonadherent tuberculosis patients. Ann N Y Acad Sci. 2001;953:216-23. http://dx.doi.org/10.1111/j.1749-6632.2001.tb11380.x
140. Veen J, Raviglione M, Rieder HL, Migliori GB, Graf P, Grzemska M, et al. Standardized tuberculosis treatment outcome monitoring in Europe. Recommendations of a Working Group of the World Health Organization (WHO) and the European Region of the International Union against Tuberculosis and Lung Disease (IUATLD) for uniform reporting by cohort analysis of treatment outcome in tuberculosis patients. Eur Respir J. 1998;12(2):505-10. http://dx.doi.org/10.1183/09031936.98.12020505